An empirical comparison of EQ-5D and SF-6D in liver transplant patients.

PubWeight™: 1.74‹?› | Rank: Top 3%

🔗 View Article (PMID 14673814)

Published in Health Econ on December 01, 2003

Authors

Louise Longworth1, Stirling Bryan

Author Affiliations

1: Health Economics Research Group, Brunel University, UK. louise.longworth@brunel.ac.uk

Articles citing this

Health status in young adults two decades after pediatric liver transplantation. Am J Transplant (2012) 1.54

Training care givers of stroke patients: economic evaluation. BMJ (2004) 1.44

Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope (2011) 1.34

Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut (2005) 1.24

A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health (2011) 1.24

Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes (2013) 1.24

Retrospective baseline measurement of self-reported health status and health-related quality of life versus population norms in the evaluation of post-injury losses. Inj Prev (2007) 1.24

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes (2007) 1.22

The Relationship between Diabetes Mellitus and Health-Related Quality of Life in Korean Adults: The Fourth Korea National Health and Nutrition Examination Survey (2007-2009). Diabetes Metab J (2011) 1.12

Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores. Eur J Health Econ (2008) 1.12

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes (2006) 1.10

Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes (2010) 1.10

Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions. Health Qual Life Outcomes (2009) 1.07

Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease. BMC Musculoskelet Disord (2013) 1.05

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain. Cost Eff Resour Alloc (2009) 1.05

Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res (2007) 0.99

Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Health Qual Life Outcomes (2014) 0.96

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. Pharmacoeconomics (2017) 0.95

Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics (2007) 0.94

Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. Eur J Health Econ (2010) 0.91

The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Eur J Health Econ (2010) 0.91

Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores. Med Care (2011) 0.90

A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation. Med Decis Making (2010) 0.89

How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Ann Rheum Dis (2007) 0.88

Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl (2009) 0.87

A comparison of four different approaches to measuring health utility in depressed patients. Health Qual Life Outcomes (2013) 0.87

An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Qual Life Res (2013) 0.84

Differences between individual and societal health state valuations: any link with personality? Med Care (2009) 0.84

The Relationship between Visual Impairment and Health-Related Quality of Life in Korean Adults: The Korea National Health and Nutrition Examination Survey (2008-2012). PLoS One (2015) 0.84

Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes (2009) 0.83

Organ quality and quality of life after liver transplantation. Liver Transpl (2011) 0.82

Association between Physical Activity and Health-Related Quality of Life in Korean: The Korea National Health and Nutrition Examination Survey IV. Korean J Fam Med (2014) 0.80

A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS One (2014) 0.80

Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients. Eur J Health Econ (2012) 0.78

Comparison of health-related quality-of-life measurement instruments in diabetic patients. Biotechnol Biotechnol Equip (2014) 0.77

Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). Eur J Health Econ (2014) 0.77

Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life. Eur J Health Econ (2014) 0.77

EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ (2014) 0.76

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer. Iran Red Crescent Med J (2016) 0.75

Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterol Res Pract (2016) 0.75

Generic Preference-based Measures for Low Back Pain: Which of Them Should Be Used? Spine (Phila Pa 1976) (2016) 0.75

Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation (2016) 0.75

Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res (2017) 0.75

Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. Qual Life Res (2017) 0.75

Articles by these authors

Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet (2011) 7.90

Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet (2010) 6.36

Let's all go to the PROM: the case for routine patient-reported outcome measurement in Canadian healthcare. Healthc Pap (2011) 4.92

Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85

Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ (2010) 3.56

Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clin Trials (2007) 2.45

Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Liver Transpl (2003) 2.23

Do patients value continuity of care in general practice? An investigation using stated preference discrete choice experiments. J Health Serv Res Policy (2007) 1.89

Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J (2005) 1.81

Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy (2004) 1.67

Discrete choice experiments in health economics. For better or for worse? Eur J Health Econ (2004) 1.65

Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ (2004) 1.54

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost (2009) 1.46

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J (2006) 1.36

Public involvement in health care priority setting: an economic perspective. Health Expect (1999) 1.32

Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study. Liver Transpl (2002) 1.22

Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework. Health Policy (2006) 1.20

Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol (2002) 1.17

Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project. Sex Transm Infect (2007) 1.13

The DAMASK trial protocol: a pragmatic randomised trial to evaluate whether GPs should have direct access to MRI for patients with suspected internal derangement of the knee. BMC Health Serv Res (2006) 1.11

Another study showing that two preference-based measures of health-related quality of life (EQ-5D and SF-6D) are not interchangeable. But why should we expect them to be? Value Health (2011) 1.10

An investigation of the construct validity of the ICECAP-A capability measure. Qual Life Res (2012) 1.07

Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. BMJ (2007) 1.05

A multinational investigation of time and traveling costs in attending anticoagulation clinics. Value Health (2008) 1.05

Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Med Decis Making (2011) 1.05

Mapping utility scores from the Barthel index. Eur J Health Econ (2011) 1.04

Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment. Genet Med (2012) 1.02

Exploration of the association between quality of life, assessed by the EQ-5D and ICECAP-O, and falls risk, cognitive function and daily function, in older adults with mobility impairments. BMC Geriatr (2012) 1.01

Improving response rates using a monetary incentive for patient completion of questionnaires: an observational study. BMC Med Res Methodol (2007) 0.99

A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes? Qual Life Res (2012) 0.98

Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol (2006) 0.97

Difficult decisions in times of constraint: criteria based resource allocation in the Vancouver Coastal Health Authority. BMC Health Serv Res (2011) 0.95

Exploring the cost-utility of stratified primary care management for low back pain compared with current best practice within risk-defined subgroups. Ann Rheum Dis (2012) 0.94

A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada. Med Care (2016) 0.94

Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol (2010) 0.92

A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study. Eur J Heart Fail (2009) 0.91

Cost-effectiveness of acupuncture care as an adjunct to exercise-based physical therapy for osteoarthritis of the knee. Phys Ther (2011) 0.90

Do the methods used to analyse missing data really matter? An examination of data from an observational study of Intermediate Care patients. BMC Res Notes (2012) 0.90

Cost-effectiveness analysis and formulary decision making in England: findings from research. Soc Sci Med (2007) 0.89

Short Form health surveys and related variants in spinal cord injury research: a systematic review. J Spinal Cord Med (2014) 0.88

Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: telemonitoring and self-management in hypertension. [ISRCTN17585681]. BMC Cardiovasc Disord (2009) 0.87

Using postal randomization to replace telephone randomization had no significant effect on recruitment of patients. J Clin Epidemiol (2007) 0.86

Post-discharge management following hip fracture--get you back to B4: a parallel group, randomized controlled trial study protocol. BMC Geriatr (2011) 0.86

Home-Based Screening for Biliary Atresia Using Infant Stool Color Cards in Canada: Quebec Feasibility Study. J Pediatr Gastroenterol Nutr (2016) 0.86

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord (2003) 0.85

Test-retest reliability of capability measurement in the UK general population. Health Econ (2014) 0.84

Development and implementation of early intervention services for young people with psychosis: case study. Br J Psychiatry (2009) 0.83

Can we afford to ignore missing data in cost-effectiveness analyses? Eur J Health Econ (2009) 0.82

Perceptions of individuals living with spinal cord injury toward preference-based quality of life instruments: a qualitative exploration. Health Qual Life Outcomes (2014) 0.82

Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial. BMC Cardiovasc Disord (2013) 0.82

Costs and health outcomes of intermediate care: results from five UK case study sites. Health Soc Care Community (2008) 0.81

The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies. Seizure (2006) 0.81

Participants' preference for type of leaflet used to feed back the results of a randomised trial: a survey. Trials (2010) 0.81

Implementing stratified primary care management for low back pain: cost-utility analysis alongside a prospective, population-based, sequential comparison study. Spine (Phila Pa 1976) (2015) 0.81

Immediate vs. delayed insertion of intrauterine contraception after second trimester abortion: study protocol for a randomized controlled trial. Trials (2011) 0.81

Trial-based clinical and economic analyses: the unhelpful quest for conformity. Trials (2013) 0.81

Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national survey. BMC Health Serv Res (2013) 0.80

Focussing both eyes on health outcomes: revisiting cataract surgery. BMC Geriatr (2012) 0.80

An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment. PLoS One (2013) 0.80

Breaking bones, breaking budgets: a clinical and economic evaluation of a prospective, randomized, practice controlled, intervention study in the prevention of accidents in primary care. Fam Pract (2002) 0.80

The relationship between staff skill mix, costs and outcomes in intermediate care services. BMC Health Serv Res (2010) 0.80

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation. Stroke (2011) 0.80

How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach. J Health Serv Res Policy (2007) 0.78

A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC Cardiovasc Disord (2004) 0.78

Development and preliminary user testing of the DCIDA (Dynamic computer interactive decision application) for 'nudging' patients towards high quality decisions. BMC Med Inform Decis Mak (2014) 0.77

A response to Birch and Gafni--some reasons to be cheerful about NICE. Health Econ Policy Law (2007) 0.75

Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods. Trials (2014) 0.75

Response to 'Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research', Jackson et al., Journal of Health Services Research & Policy 2011;16:141-6. J Health Serv Res Policy (2012) 0.75

Darzi on NICE: the case for clinician engagement in HTA. Health Econ (2008) 0.75

Exploring psychometric properties of the SF-6D, a preference-based health-related quality of life measure, in the context of spinal cord injury. Qual Life Res (2014) 0.75

Compulsion: the key to US health care reform. J Health Serv Res Policy (2012) 0.75

Does the process of deliberation change individuals' health state valuations? An exploratory study using the person trade-off technique. Value Health (2013) 0.75

Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials. Health Econ (2012) 0.75